Express Scripts Holding Co (ESRX)

72.67
NASDAQ : Health Care
Prev Close 72.67
Day Low/High 0.00 / 0.00
52 Wk Low/High 64.46 / 80.02
Avg Volume 4.37M
Exchange NASDAQ
Shares Outstanding 616.62M
Market Cap 45.11B
EPS 3.60
P/E Ratio 17.34
Div & Yield N.A. (N.A)

Latest News

See How Express Scripts Holding Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How Express Scripts Holding Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that Express Scripts Holding Co is the #84 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017

What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017

Every January at 'JPM,' investors take the pulse of the biotech industry for the coming year.

17 Thoughts on Biotech Stocks to Kick Off 2017

17 Thoughts on Biotech Stocks to Kick Off 2017

Adam Feuerstein compiles a list of questions, thoughts, declarations, catalysts and observations about biotech stocks to help investors prepare for the year ahead.

Doug Kass' Top Pick for 2017: Short QQQ

Doug Kass' Top Pick for 2017: Short QQQ

Kass' trade of the year for 2017 is to short the PowerShares QQQ Trust ETF.

My Top Pick for 2017: Short QQQ

My Top Pick for 2017: Short QQQ

Six reasons why the Nasdaq 100 ETF seems ready to pull back.

Inside Eli Lilly's Surging Stock Price

Inside Eli Lilly's Surging Stock Price

For the first time in three years, Eli Lilly's guidance for next year has topped Wall Street's consensus estimates.

Eli Lilly's 2017 Guidance Pleases Investors as Shares Soar

Eli Lilly's 2017 Guidance Pleases Investors as Shares Soar

Eli Lilly posts better-than-expected guidance for 2017, sending its share price soaring in premarket trading.

Dow Snaps Seven-Day Win Streak After Fed Ups Expected 2017 Rate Hikes

Dow Snaps Seven-Day Win Streak After Fed Ups Expected 2017 Rate Hikes

Stocks retreat from records on Wednesday after the Federal Reserve increases its forecasts for next year's rate hikes.

Express Scripts Guidance Fails to Thrill Wall Street

Express Scripts Guidance Fails to Thrill Wall Street

Express Scripts revealed its 2017 financial guidance earlier today, and the Street is hardly enthralled, with shares falling sharply.

Stock Losses Escalate as Fed Ups Expected 2017 Rates Hikes

Stock Losses Escalate as Fed Ups Expected 2017 Rates Hikes

Stocks extend losses on Wednesday after the Federal Reserve raises interest rates for the second time in a decade.

Stocks Slip After Retail Sales Pull Growth Projections Lower

Stocks Slip After Retail Sales Pull Growth Projections Lower

Stocks slip Wednesday after a drop in retail sales pulls estimates for fourth-quarter U.S. GDP lower.

The Worst Biopharma CEOs of 2016 Are ...

The Worst Biopharma CEOs of 2016 Are ...

There was plenty of shame to spread around, but Theranos CEO Elizabeth Holmes' loathsome mix of arrogance, incompetence and duplicity makes her the Worst CEO of 2016.

Express Scripts Shares Plummet Despite Few Concerns on Trump Presidency

Express Scripts Shares Plummet Despite Few Concerns on Trump Presidency

The Express Scripts CEO said Wednesday that Trump's impending presidency won't impact guidance for fiscal year 2017.

U.S. Stocks Slip Before Fed Meeting; Retail Sales Miss Estimates

U.S. Stocks Slip Before Fed Meeting; Retail Sales Miss Estimates

U.S. stocks lost steam Wednesday, as the markets awaited the Federal Reserve's closely watched rate hike decision.

Stock Futures Fall as Producer Prices Rise, Retail Sales Miss

Stock Futures Fall as Producer Prices Rise, Retail Sales Miss

Stock futures hold mixed on Wednesday morning as producer prices beat forecasts, while retail sales come in below forecasts.

Eli Lilly Teams With Express Scripts to Offer Discounted Insulin

Eli Lilly Teams With Express Scripts to Offer Discounted Insulin

Shares of Eli Lilly were higher Tuesday after announcing that starting January of 2017, customers will be able to purchase insulin at a discount of up to 40%.

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts are seeking to avoid potential bad press over high insulin prices.

Lilly Announces Program To Provide Insulin At Discounted Prices

Lilly Announces Program To Provide Insulin At Discounted Prices

Starting January 1, people who pay the highest out-of-pocket prices for insulin, such as those who pay full retail price at the pharmacy, may directly benefit from 40 percent discount

Express Scripts Announces Enhancements To Industry Leading SafeGuardRx(SM) Programs

Express Scripts Announces Enhancements To Industry Leading SafeGuardRx(SM) Programs

- Hepatitis Cure Value Program® expands covered treatments to include both Viekira Pak™ and Harvoni® in 2017

Analysts Skeptical of Andrew Left's Express Scripts Criticism

Analysts Skeptical of Andrew Left's Express Scripts Criticism

Analysts blame drug companies, not pharmacy benefit managers, for the rising cost of drugs.

Horizon Fails Late-Stage Freidreich's Ataxia Trial

Horizon Fails Late-Stage Freidreich's Ataxia Trial

Shares spiraled downward in early trading, but Mizuho's Irina Koffler expects the stock will plateau by the end of the day.

Express Scripts Earns Top Marks In 2017 Corporate Equality Index

Express Scripts Earns Top Marks In 2017 Corporate Equality Index

Human Rights Campaign Foundation Awards Perfect Score to Express Scripts for LGBT Workplace Equality

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts

Jim Cramer says he prefers Celgene to Gilead, and Walgreens Boots Alliance to Express Scripts.

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.

Bullish and Bearish Chart Reversals

What stocks have changed direction in the past week.

Shares of Pharmacy Benefit Managers Cheer Trump Presidency, Though Uncertainty Remains

Shares of Pharmacy Benefit Managers Cheer Trump Presidency, Though Uncertainty Remains

PBM stocks are rallying on diminished fears of a drug pricing crackdown, though President-Elect Donald Trump has yet to detail specific proposals.